PLA2G4A encodes a calcium-dependent cytosolic phospholipase A2 (cPLA2) critical for lipid remodeling and inflammatory signaling. The recombinant partial protein retains functional domains necessary for substrate binding and catalysis.
PLA2G4A-derived arachidonic acid fuels prostaglandin and leukotriene synthesis, linking it to inflammation and immune responses .
Inhibitors like AACOCF3 and ASB 14780 target its catalytic site, reducing pro-inflammatory lipid mediators .
PLA2G4A activity is essential for producing infectious hepatitis C virus (HCV) and Dengue virus particles, likely by shaping lipid membranes for virion assembly .
Pharmacological inhibition reduces viral infectivity by >100-fold, highlighting its therapeutic potential .
In spinal cord injury models, PLA2G4A inhibition mitigates secondary tissue damage and improves motor recovery, suggesting neuroprotective applications .
Expression: Recombinant partial PLA2G4A is often expressed in insect cells (e.g., baculovirus) to ensure proper folding and phosphorylation at regulatory sites (e.g., Ser-505) .
Purity: ≥87% purity achieved via affinity chromatography, validated by SDS-PAGE and functional assays .
Storage: Stable at -80°C in lyophilized form, avoiding freeze-thaw cycles .
Lipid Mediator Biosynthesis:
Therapeutic Targeting:
In Xenopus tropicalis, as in other vertebrates, cytosolic phospholipase A2 (PLA2G4A) plays critical roles in membrane lipid remodeling and biosynthesis of lipid mediators involved in inflammatory responses. The enzyme selectively hydrolyzes arachidonyl phospholipids in the sn-2 position, releasing arachidonic acid, which serves as a precursor for eicosanoid biosynthesis via the cyclooxygenase pathway . This hydrolysis reaction simultaneously produces lysophospholipids that can be converted into platelet-activating factor.
In developmental contexts, PLA2G4A is particularly important for processes requiring lipid signaling cascades. The protein demonstrates calcium-dependent phospholipase and lysophospholipase activities, with activation occurring through increased intracellular Ca²⁺ levels and phosphorylation events that trigger its translocation from cytosolic and nuclear compartments to perinuclear membrane vesicles .
While the search results don't provide specific comparative data between Xenopus tropicalis PLA2G4A and mammalian orthologs, general molecular principles suggest conservation of key functional domains. The protein belongs to the cytosolic phospholipase A2 group IV family and contains calcium-binding domains that regulate its activity .
Similar to human PLA2G4A, the Xenopus variant likely demonstrates:
Calcium-dependent activation mechanisms
Selectivity for arachidonoyl phospholipids at the sn-2 position
Translocation properties following activation
Roles in inflammatory response and lipid signaling pathways
The partial recombinant form may contain the catalytic domain responsible for phospholipase activity but might lack some regulatory domains present in the full-length protein.
Recombinant partial PLA2G4A from Xenopus tropicalis typically consists of selected functional domains of the native protein expressed in heterologous systems. While specific details about the Xenopus tropicalis variant are not provided in the search results, the partial recombinant form would likely retain the catalytic domain necessary for phospholipase A2 activity .
Production systems for recombinant proteins generally include bacterial (E. coli), yeast, baculovirus-infected insect cells, or mammalian expression systems. Each system offers distinct advantages:
| Expression System | Advantages | Limitations |
|---|---|---|
| E. coli | High yield, cost-effective, rapid | May lack post-translational modifications, potential inclusion bodies |
| Yeast | Post-translational processing, higher yield than mammalian | May have different glycosylation patterns |
| Baculovirus | Higher eukaryotic post-translational modifications | More complex, moderate yield |
| Mammalian cells | Native-like post-translational modifications | Lower yield, higher cost, longer production time |
The partial nature of the recombinant protein may be intentional to improve solubility, enhance expression levels, or isolate specific functional domains for research applications .
Assaying recombinant Xenopus PLA2G4A activity requires careful consideration of several conditions that mimic its physiological activation state. The enzyme is calcium-dependent and requires specific pH and temperature conditions that approximate the Xenopus physiological environment .
A typical assay protocol would include:
Buffer composition: pH 7.4-8.0 phosphate or Tris buffer with 1-5 mM CaCl₂
Temperature: 25-30°C (appropriate for a poikilothermic organism like Xenopus)
Substrate preparation: Phospholipid substrates containing arachidonoyl groups at the sn-2 position
Activation: Addition of Ca²⁺ to final concentration of 1-5 mM
Activity measurement: Quantification of released arachidonic acid or lysophospholipids using chromatographic methods or coupled enzymatic assays
Researchers should note that PLA2G4A requires activation via calcium and often benefits from phosphorylation. Pre-incubation with protein kinases and ATP can enhance activity, mimicking the physiological activation cascades .
Establishing an expression system for recombinant Xenopus tropicalis PLA2G4A requires several key steps:
Gene synthesis or cloning: Obtain the coding sequence for Xenopus tropicalis PLA2G4A. For partial protein expression, identify the functional domains of interest.
Expression vector selection: Choose an appropriate expression vector containing:
Strong promoter suitable for your expression system
Affinity tag sequence (His6, GST, etc.) for purification
Appropriate selection marker
Expression system selection: Based on Table 1, select an expression system that balances yield requirements with protein functionality needs .
Optimization of expression conditions:
For E. coli: Test various strains (BL21(DE3), Rosetta), induction temperatures (16-37°C), and IPTG concentrations
For eukaryotic systems: Optimize transfection/infection parameters, culture medium, and harvest timing
Purification strategy:
Immobilized metal affinity chromatography for His-tagged proteins
Glutathione affinity for GST-tagged proteins
Ion exchange or size exclusion chromatography for further purification
For challenging proteins, consider adding solubility enhancers (SUMO tag) or using specialized expression strains designed for membrane-associated proteins .
While the search results don't provide specific antibodies for Xenopus tropicalis PLA2G4A, there are several approaches for detecting and studying this protein:
Cross-reactive antibodies: Human, mouse, and rat PLA2G4A antibodies may cross-react with the Xenopus ortholog due to evolutionary conservation. Available antibodies include :
Conventional unmodified antibodies for techniques like Western blotting, ELISA, and immunohistochemistry
Conjugated antibodies (HRP, FITC, or biotin) for specialized applications
Custom antibody development: Using recombinant Xenopus tropicalis PLA2G4A as an immunogen to generate specific antibodies.
Detection methods:
Western blotting for protein expression levels and post-translational modifications
Immunohistochemistry for tissue localization
Immunofluorescence for subcellular localization
ELISA for quantitative detection
Chromatin immunoprecipitation for DNA-protein interaction studies, as demonstrated in Xenopus tissues
When using antibodies, validation is essential through techniques such as knockout controls, peptide competition assays, or detection of recombinant protein standards .
The expression patterns of PLA2G4A during Xenopus development and metamorphosis likely correlate with stages requiring active lipid signaling and inflammatory responses. While the search results don't provide specific data for PLA2G4A expression in Xenopus tropicalis, metamorphosis studies in this species offer insights into gene regulation mechanisms that would apply to PLA2G4A .
Xenopus metamorphosis involves comprehensive remodeling of tissues under thyroid hormone (TH) control. Based on studies of metamorphic gene regulation:
Gene expression changes dramatically during metamorphosis, with peak regulation at Nieuwkoop-Faber stage 62 (NF62), when liganded thyroid hormone receptors (TRs) actively regulate transcription .
PLA2G4A expression likely follows tissue-specific patterns correlated with:
Inflammatory processes during tissue remodeling
Lipid signaling changes as tissues transform from larval to adult forms
Calcium signaling pathways activated during development
Techniques for studying PLA2G4A expression during development include:
Stage-specific RNA-seq to track transcript levels
Chromatin immunoprecipitation (ChIP) to identify potential thyroid hormone response elements in the PLA2G4A promoter
Whole-mount in situ hybridization to visualize tissue-specific expression patterns
Understanding these expression patterns could reveal new roles for PLA2G4A in amphibian development and tissue remodeling, particularly in relation to inflammatory signaling during metamorphosis .
Analyzing PLA2G4A regulation at transcriptional and post-transcriptional levels presents several technical and biological challenges:
Transcriptional regulation complexities:
Identifying tissue-specific promoters and enhancers that regulate PLA2G4A expression
Characterizing transcription factor binding sites using techniques like ChIP-seq
Understanding three-dimensional chromatin organization, including topologically associating domains (TADs) that may influence PLA2G4A expression
Post-transcriptional regulation challenges:
Methodological considerations:
RNA extraction and quality control from different Xenopus tissues
Poly(A) mRNA enrichment before library preparation
Advanced computational analysis pipelines for detecting subtle regulation events
The analysis becomes particularly challenging when studying rapid adaptive responses, where post-transcriptional dynamics may change quickly and experimental conditions must be precisely controlled .
CRISPR/Cas9 genome editing offers powerful approaches to study PLA2G4A function in Xenopus tropicalis:
Knockout strategy:
Design sgRNAs targeting early exons of PLA2G4A
Inject Cas9 protein and sgRNAs into fertilized Xenopus tropicalis eggs
Screen F0 embryos for mosaic mutations and raise to adulthood
Breed F0 founders to generate F1 heterozygotes with germline mutations
Establish homozygous knockout lines through F1 crosses
Domain-specific editing:
Target specific functional domains (catalytic site, calcium-binding domain)
Design repair templates for homology-directed repair to introduce precise mutations
Analyze the effects on protein function and cellular phenotypes
Phenotypic analysis of PLA2G4A mutants:
Assess development progression and metamorphosis timing
Evaluate inflammatory responses in different tissues
Measure arachidonic acid release and eicosanoid production
Analyze calcium-dependent signaling pathways
Complementation studies:
Rescue knockout phenotypes with wildtype or mutant mRNA injections
Express tagged versions for localization studies
Introduce orthologous genes to assess functional conservation
This approach allows precise dissection of PLA2G4A function in developmental contexts, inflammatory responses, and tissue remodeling during metamorphosis.
PLA2G4A has evolved to maintain its critical function in lipid signaling across vertebrate lineages while adapting to species-specific physiological requirements. The Xenopus tropicalis ortholog provides unique evolutionary insights:
Functional conservation:
Adaptive specializations:
Temperature sensitivity adaptations in poikilothermic animals like Xenopus compared to mammals
Potential differences in regulatory domains reflecting distinct signaling contexts
Specialized roles during metamorphosis, a process absent in mammals
Comparative analysis approaches:
Sequence alignment of catalytic and regulatory domains across species
Structural modeling to identify species-specific features
Functional assays comparing enzymatic properties under different conditions
The amphibian PLA2G4A represents an important evolutionary intermediate between fish and mammals, potentially revealing mechanisms of adaptation during vertebrate terrestrialization.
Comparative functional studies of PLA2G4A across species require integrated approaches:
Biochemical characterization:
Side-by-side enzymatic assays of recombinant PLA2G4A from different species
Determination of kinetic parameters (Km, Vmax) under standardized conditions
Substrate preference analysis using diverse phospholipid substrates
Calcium sensitivity and activation thresholds comparison
Cell-based functional assays:
Heterologous expression in conserved cell backgrounds
Complementation studies in knockout cell lines
Subcellular localization comparison using fluorescent protein fusions
Response to stimuli that activate phospholipase pathways
Structural biology approaches:
X-ray crystallography or cryo-EM of recombinant proteins
Molecular dynamics simulations to assess conformational differences
Hydrogen-deuterium exchange mass spectrometry for dynamics comparison
In vivo cross-species approaches:
Rescue experiments using orthologous genes in knockout models
Humanized animal models expressing mammalian PLA2G4A in Xenopus
Chimeric proteins to identify species-specific functional domains
These comparative approaches can reveal both conserved mechanisms and species-specific adaptations in PLA2G4A function across evolutionary time.
Optimizing recombinant Xenopus tropicalis PLA2G4A expression requires addressing several key challenges:
Expression system selection:
Expression optimization strategies:
Temperature: Lower temperatures (16-25°C) often improve folding for complex proteins
Induction conditions: Reduced inducer concentration with extended expression time
Media formulation: Enriched media with osmotic stabilizers for membrane-associated proteins
Codon optimization: Adjust codons for the expression host to improve translation efficiency
Solubility enhancement approaches:
Fusion partners: SUMO, MBP, or TRX tags to improve solubility
Solubilizing agents: Mild detergents for membrane-associated domains
Chaperone co-expression: GroEL/ES, DnaK/J/GrpE systems to assist folding
Activity preservation strategies:
Calcium supplementation during purification
Reducing agents to preserve cysteine residues
Lipid reconstitution for membrane-associated domains
Stabilizing excipients: Glycerol, specific phospholipids, osmolytes
Systematic optimization of these parameters through small-scale expression trials before scaling up can significantly improve both yield and activity .
Designing effective knockout or knockdown experiments for PLA2G4A in Xenopus tropicalis requires careful planning:
Target selection strategies:
For CRISPR/Cas9: Target early exons or critical functional domains
For morpholinos: Target translation start site or exon-intron junctions
For RNAi: Select unique sequences not present in paralogous genes
Control design considerations:
Off-target assessment tools for CRISPR guide RNAs
Mismatch controls for morpholinos
Scrambled sequence controls for RNAi
Rescue experiments with wild-type mRNA to confirm specificity
Delivery methods optimization:
Microinjection timing: One-cell stage for uniform distribution
Injection location: Animal pole for broad distribution, specific blastomeres for targeted knockdown
Electroporation parameters for tissue-specific delivery in later stages
Validation approaches:
Genomic PCR and sequencing for CRISPR edits
RT-PCR to confirm splicing alterations with morpholinos
Western blotting to verify protein reduction
Enzymatic activity assays to confirm functional knockdown
Phenotypic analysis planning:
Developmental staging to identify critical periods
Tissue-specific markers to assess localized effects
Lipid mediator profiling to confirm biochemical consequences
Inflammation models to test functional outcomes
Careful documentation of developmental timing, environmental conditions, and complete characterization of molecular alterations are essential for reproducible results .
Adapting chromatin immunoprecipitation (ChIP) protocols for Xenopus tissues requires several modifications to standard protocols:
Sample preparation considerations:
Chromatin fragmentation strategies:
Sonication parameters: Lower power settings with increased cycle numbers
Fragment size target: 200-500 bp for standard ChIP, 100-300 bp for ChIP-seq
Quality control: Agarose gel verification of fragmentation efficiency
Immunoprecipitation optimization:
Analysis approaches:
qPCR targets: Promoter regions, potential enhancers, and intronic regulatory elements
ChIP-seq library preparation: Specialized kits for limited material
Bioinformatic analysis: Xenopus tropicalis genome alignment and peak calling
A typical workflow based on successful Xenopus experiments includes:
Chromatin isolation from whole brain or specific tissues
Fragmentation via sonication
Immunoprecipitation using 5 μg chromatin per reaction
This approach can identify transcription factor binding sites and histone modifications associated with PLA2G4A regulation during development and in response to physiological stimuli.